Zealand Pharma fined by Danish financial supervisory authority
The Danish FSA claims the biotech firm hasn’t released information concerning a major stakeholder’s shareholding, which will cost the firm DKK 60,000 (USD 8,246) in penalties.
by marketwire, translated by daniel pedersen
Danish biotech firm Zealand Pharma has been fined DKK 60,000 (USD 8,246) by Denmark’s Financial Supervisory Authority, the FSA, according to a press release from the agency.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Zealand Pharma to delist in US
For subscribers
Zealand Pharma hires head of regulatory affairs
For subscribers
Zealand Pharma enters AI partnership with Iktos
For subscribers
